These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3524441)

  • 1. Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study.
    Herzog C; Berger R; Fernex M; Friesecke K; Havas L; Just M; Dubach UC
    Antiviral Res; 1986 May; 6(3):171-6. PubMed ID: 3524441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
    Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
    J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental coronavirus colds with intranasal alpha-2b interferon.
    Turner RB; Felton A; Kosak K; Kelsey DK; Meschievitz CK
    J Infect Dis; 1986 Sep; 154(3):443-7. PubMed ID: 3016111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
    Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
    N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.
    Samo TC; Greenberg SB; Couch RB; Quarles J; Johnson PE; Hook S; Harmon MW
    J Infect Dis; 1983 Sep; 148(3):535-42. PubMed ID: 6619578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.
    Douglas RM; Moore BW; Miles HB; Davies LM; Graham NM; Ryan P; Worswick DA; Albrecht JK
    N Engl J Med; 1986 Jan; 314(2):65-70. PubMed ID: 3001518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose.
    Samo TC; Greenberg SB; Palmer JM; Couch RB; Harmon MW; Johnson PE
    J Infect Dis; 1984 Aug; 150(2):181-8. PubMed ID: 6381611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
    Hayden FG; Kaiser DL; Albrecht JK
    Antimicrob Agents Chemother; 1988 Feb; 32(2):224-30. PubMed ID: 2834996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal tolerance and histopathologic effects of a novel synthetic interferon, rIFN-alpha Con1.
    Hayden FG; Innes DJ; Mills SE; Levine PA
    Antiviral Res; 1988 Dec; 10(4-5):225-34. PubMed ID: 2852485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
    Farr BM; Gwaltney JM; Adams KF; Hayden FG
    Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families.
    Monto AS; Schwartz SA; Albrecht JK
    Antimicrob Agents Chemother; 1989 Mar; 33(3):387-90. PubMed ID: 2543280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection.
    Monto AS; Shope TC; Schwartz SA; Albrecht JK
    J Infect Dis; 1986 Jul; 154(1):128-33. PubMed ID: 3011917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal interferon for contact prophylaxis against common cold in families.
    Herzog C; Just M; Berger R; Havas L; Fernex M
    Lancet; 1983 Oct; 2(8356):962. PubMed ID: 6138515
    [No Abstract]   [Full Text] [Related]  

  • 16. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers.
    Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Freestone DS; Shepherd WM
    J Interferon Res; 1984; 4(4):535-41. PubMed ID: 6094684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2.
    Phillpotts RJ; Scott GM; Higgins PG; Wallace J; Tyrrell DA; Gauci CL
    Antiviral Res; 1983 Aug; 3(2):121-36. PubMed ID: 6312877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers.
    Higgins PG; Al-Nakib W; Willman J; Tyrrell DA
    J Interferon Res; 1986 Apr; 6(2):153-9. PubMed ID: 3014018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers.
    Tannock GA; Gillett SM; Gillett RS; Barry RD; Hensley MJ; Herd R; Reid AL; Saunders NA
    Epidemiol Infect; 1988 Dec; 101(3):611-21. PubMed ID: 3215290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.